Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov 15;12(1):6586.
doi: 10.1038/s41467-021-26690-1.

Detrimental proarrhythmogenic interaction of Ca2+/calmodulin-dependent protein kinase II and NaV1.8 in heart failure

Affiliations

Detrimental proarrhythmogenic interaction of Ca2+/calmodulin-dependent protein kinase II and NaV1.8 in heart failure

Philipp Bengel et al. Nat Commun. .

Abstract

An interplay between Ca2+/calmodulin-dependent protein kinase IIδc (CaMKIIδc) and late Na+ current (INaL) is known to induce arrhythmias in the failing heart. Here, we elucidate the role of the sodium channel isoform NaV1.8 for CaMKIIδc-dependent proarrhythmia. In a CRISPR-Cas9-generated human iPSC-cardiomyocyte homozygous knock-out of NaV1.8, we demonstrate that NaV1.8 contributes to INaL formation. In addition, we reveal a direct interaction between NaV1.8 and CaMKIIδc in cardiomyocytes isolated from patients with heart failure (HF). Using specific blockers of NaV1.8 and CaMKIIδc, we show that NaV1.8-driven INaL is CaMKIIδc-dependent and that NaV1.8-inhibtion reduces diastolic SR-Ca2+ leak in human failing cardiomyocytes. Moreover, increased mortality of CaMKIIδc-overexpressing HF mice is reduced when a NaV1.8 knock-out is introduced. Cellular and in vivo experiments reveal reduced ventricular arrhythmias without changes in HF progression. Our work therefore identifies a proarrhythmic CaMKIIδc downstream target which may constitute a prognostic and antiarrhythmic strategy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1. CaMKIIδc interacts with NaV1.8 in human myocardium and isolated cardiomyocytes.
a Co-immunoprecipitation of CaMKIIδc and NaV1.8 from left ventricular homogenates of human non-failing and failing hearts (NF: n = 7; HF: n = 7). b Co-localization of CaMKIIδc and NaV1.8 in human failing cardiomyocytes with immunofluorescence staining. Scale bar: 10 µm (staining was performed in cardiomyocytes isolated from five heart failure patients).
Fig. 2
Fig. 2. Reduced INaL upon NaV1.8 inhibition in human failing and mouse CaMKIIδc transgenic cardiomyocytes, and in SCN10A knockout iPSC-cardiomyocytes.
a Original traces of INaL in WT and CaMKIIδc+/T mouse ventricular cardiomyocytes elicited using the protocol shown in the inset. b Mean data ± SEM along with individual values shown in the graph plotting WT (n = 10 cells/5 mice) and CaMKIIδc+/T (untreated: n = 15 cells/7 mice; A-806467: n = 12 cells/7 mice; PF-01247324: n = 12 cells/7 mice). Probability vs. untreated (One-way ANOVA with post hoc Bonferroni’s correction). c Original traces of INaL from human failing ventricular cardiomyocytes elicited using the protocol shown in the inset. d Mean data ± SEM along with individual values shown in the graph plotting (untreated: n = 14 cells/8 patients; AIP: n = 8 cells/5 patients; PF-01247324: n = 10 cells/6 patients; AIP + PF-01247324 = 9 cells/5 patients). Probability vs. untreated (One-way ANOVA with post hoc Bonferroni’s correction). e Original traces of INaL from human ventricular SCN10A knockout iPSC-cardiomyocytes elicited using the protocol shown in the inset. f Mean data ± SEM along with individual values shown in the graph plotting (control + Iso: n = 19 cells/3 cardiac differentiations; control + Iso + PF: n = 4 cells/3 differentiations; SCN10A knockout (KO) + Iso: n = 11 cells/3 differentiations; KO + Iso + PF-01247324 = 12 cells/3 differentiations). Probability vs. control + Iso (One-way ANOVA with post hoc Bonferroni’s correction).
Fig. 3
Fig. 3. Effects NaV1.8 inhibition on intracellular Ca2+ handling.
a Representative line scan images of CaMKIIδc+/T ventricular cardiomyocytes. b CaSpF data shown as mean ± SEM for wildtype (WT) (untreated: n = 58 cells/4 mice; PF-01247324: n = 41 cells/4 mice; A-806467: n = 41 cells/4 mice) and CaMKIIδc+/T (untreated: n = 122 cells/8 mice; PF-01247324: n = 105 cells/7 mice; A-806467: n = 101 cells/8 mice). Data were analyzed by one-way ANOVA with post hoc Bonferroni’s correction. c Representative line scan images of human failing ventricular cardiomyocytes. d Data shown as mean ± SEM (untreated: n = 123 cells/14 patients; Autocamtide-2-related inhibitory peptide (AIP): n = 105 cells/15 patients; PF-01247324: n = 59 cells/10 patients; AIP + PF-01247324 = 89 cells/13 patients). Data were analyzed by one-way ANOVA with post hoc Bonferroni’s correction, Probability vs. untreated. e Representative Ca2+ transients stimulated at 1 Hz and caffeine-induced Ca2+ transients in ventricular cardiomyocytes from CaMKIIδc+/T under untreated conditions. f Mean data ± SEM show no effect of PF-01347324 treatment on Ca2+ transient amplitude at 1.0, 2.0, and 4.0 Hz stimulation (n = 13 cells/5 mice) compared to untreated (n = 10 cells/5 mice). g Ca2+-transient decay (90% of Ca2+-removal) RT90 was unchanged in PF-01347324-treated cells (n = 11 cells/5 mice) compared to untreated (n = 8 cells/5 mice). Data were presented as mean values ± SEM. h Representative Ca2+ transients stimulated at 1 Hz and caffeine-induced Ca2+ transients in ventricular cardiomyocytes from CaMKIIδc+/T treated with PF-01247324. i Diastolic Ca2+ after addition of PF-01347324 (n = 13 cells/5 mice) compared to untreated cells (n = 10 cells/5 mice) at different stimulation frequencies was unchanged (one-way ANOVA with post hoc Bonferroni’s correction, Fig. 3f, g, i). Data were presented as mean values ± SEM. j Mean and individual values ± SEM of caffeine-induced Ca2+ transients (untreated: n = 7 cells/4 mice, PF-01247324: n = 11 cells/5 mice) did not differ between the groups (Student’s t-test). k Ca2+-reuptake into the SR was not affected by inhibition of NaV1.8 (untreated: n = 7 cells/4 mice, PF-01247324: n = 11 cells/5 mice), analyzed by Student’s t-test. Data were presented as mean values ± SEM.
Fig. 4
Fig. 4. Knockout of the Scn10a (NaV1.8) gene in CaMKIIδc+/T mice improves survival.
a Survival curve of CaMKIIδc+/T and SCN10A−/−/CaMKIIδc+/T (43 vs. 64 animals, median survival 72 vs. 98 days, blinded analysis). Log-rank (Mantel–Cox test and Gehan–Breslow–Wilcoxon test (two-tailed analysis) were performed to calculate the survival percentage of mice. Probability vs CaMKIIδc+/T. b Hearts from WT, SCN10A−/−, CaMKIIδc+/T, and SCN10A−/−/CaMKIIδc+/T mice. c Ratio of heart weight to tibia length as a parameter of cardiac hypertrophy. CaMKIIδc+/T and SCN10A−/−/CaMKIIδc+/T showed a significant increase in this ratio compared to WT and SCN10A−/− mice. Data were analyzed by one-way ANOVA with post hoc Bonferroni’s correction. (N = hearts studied, WT = 14, SCN10A−/− = 16, CaMKIIδc+/T = 13, and SCN10A−/−/CaMKIIδc+/T = 23). Data were presented as mean values ± SEM. d Original histological wheat germ agglutinin staining from WT, SCN10A−/−, CaMKIIδc+/T, and SCN10A−/−/CaMKIIδc+/T mice. Scale bars = 75 µm. Stainings were produced from different sections and three different regions (basal, mid-ventricular, and apical) of each heart studied. e Cardiomyocyte cross-sectional-area (CSA) as a parameter for cellular hypertrophy. CaMKIIδc+/T and SCN10A−/−/CaMKIIδc+/T showed a significant increase in CSA compared to WT and SCN10A−/− mice. CSA in CaMKIIδc+/T and SCN10A−/−/CaMKIIδc+/T mice did not significantly differ. Data were analyzed by one-way ANOVA with post hoc Bonferroni’s correction. N = hearts studied (>300 cardiomyocytes were studied per heart, from different sections and different regions (basal, mid-ventricular, apical), WT = 5 hearts, SCN10A−/− = 5 hearts, CaMKIIδc+/T = 4 hearts, SCN10A−/−/CaMKIIδc+/T = 5 hearts. Data were presented as mean values ± SEM. f Original echocardiography recordings from WT, SCN10A−/−, CaMKIIδc+/T, and SCN10A−/−/CaMKIIδc+/T at M-mode in 12–13- week-old mice. g Echocardiography recordings revealed a decrease in left ventricular ejection fraction (EF) in CaMKIIδc+/T (six mice) and SCN10A−/−/CaMKIIδc+/T (six mice) compared to WT (seven mice) or SCN10A−/− (eight mice) (p < 0.0001(one-way ANOVA with post hoc Bonferroni’s correction). Data were presented as mean values ± SEM. h Echocardiography recordings revealed a significant increase in left ventricular end-diastolic diameter (LVEDD) in CaMKIIδc+/T (six mice) and SCN10A−/−/CaMKIIδc+/T (six mice) compared to WT (seven mice) or SCN10A−/− (eight mice) (p < 0.0001). LVEDD was not significantly different in WT vs SCN10A−/− or CaMKIIδc+/T vs SCN10A−/−/CaMKIIδc+/T (one-way ANOVA with post hoc Bonferroni’s correction). Data were presented as mean values ± SEM.
Fig. 5
Fig. 5. Knockout of Scn10a (NaV1.8) in CaMKIIδc+/T mice (SCN10A−/−/CaMKIIδc+/T) significantly reduces INaL and proarrhythmic triggers.
a Original traces of INaL in WT, SCN10A−/−, CaMKIIδc+/T, and SCN10A−/−/CaMKIIδc+/T mouse ventricular cardiomyocytes elicited using the protocol shown in the inset. b Mean data ± SEM along with individual values shown in the graph plotting (WT: n = 7 cells/4 mice, SCN10A−/− n = 10 cells/5 mice, CaMKIIδc+/T: n = 9 cells/5 mice; SCN10A−/−/CaMKIIδc+/T: n = 4 cells/4 mice), there was a significantly reduced INaL in SCN10A−/−/CaMKIIδc+/T cardiomyocytes compared to CaMKIIδc+/T. Data were analyzed by one-way ANOVA with post hoc Bonferroni’s correction. c Original traces of action potentials showing triggered action potentials originating from delayed afterdepolarizations (DADs) in CaMKIIδc+/T and SCN10A−/−/CaMKIIδc+/T cardiomyocytes. d Graph of mean data ± SEM along with individual values showing DADs per minute in WT (n = 10 cells/5 mice), SCN10A−/− (n = 12 cells/5 mice), CaMKIIδc+/T (n = 21 cells/5 mice) and SCN10A−/−/CaMKIIδc+/T (n = 15 cells/5 mice) cardiomyocytes. There were significantly less events of afterdepolarizations in SCN10A−/−/CaMKIIδc+/T compared to CaMKIIδc+/T cardiomyocytes. Data were analyzed by one-way ANOVA with the post hoc two-stage step-up method of Benjamini, Krieger, and Yekutieli. e Original traces of action potential showing early afterdepolarizations (EADs) in CaMKIIδc+/T and SCN10A−/−/CaMKIIδc+/T cardiomyocytes. f Graph of mean data ± SEM along with individual values showing EADs per minute in WT (n = 10 cells/5 mice), SCN10A−/− (n = 12 cells/5 mice), CaMKIIδc+/T (n = 21 cells/5 mice) and SCN10A−/−/CaMKIIδc+/T (n = 16 cells/5 mice) cardiomyocytes. There were significantly less events of afterdepolarizations in SCN10A−/−/CaMKIIδc+/T compared to CaMKIIδc+/T cardiomyocytes. Data were analyzed by one-way ANOVA with the post hoc two-stage step-up method of Benjamini, Krieger, and Yekutieli. g Original confocal line scans images of CaMKIIδc+/T and SCN10A−/−/CaMKIIδc+/T cardiomyocytes showing diastolic Ca2+ waves. h Percentage of cells exhibiting waves was significantly less in SCN10A−/−/CaMKIIδc+/T (n = 74 cells/7 mice) compared to CaMKIIδc+/T (n = 104 cells/9 mice). Data were analyzed by Chi-square test, two-tailed analysis. i Significantly decreased number of Ca2+ waves per minute in SCN10A−/−/CaMKIIδc+/T compared to CaMKIIδc+/T. Data were analyzed by one-way ANOVA with post hoc Bonferroni’s correction. Cells/mice studied, WT: n = 48 cells/5 mice, SCN10A−/−: n = 52 cells/5 mice, CaMKIIδc+/T: n = 104 cells/9 mice; SCN10A−/−/CaMKIIδc+/T: n = 74 cells/7 mice. Data were presented as mean values ± SEM.
Fig. 6
Fig. 6. SCN10A−/−/CaMKIIδc+/T exhibit less in vivo arrhythmias compared to CaMKIIδc+/T mice.
a Original ECG traces from telemetry recordings of 10-week-old CaMKIIδc+/T and SCN10A−/−/CaMKIIδc+/T mice showing ventricular arrhythmias. b Unchanged activity levels in SCN10A−/−/CaMKIIδc+/T compared to CaMKIIδc+/T (CaMKIIδc+/T (four mice); SCN10A−/−/CaMKIIδc+/T (three mice), four individual recordings each). Data were presented as mean values ± SEM, analyzed by unpaired two-tailed Student’s t-test. c Mean values of premature ventricular contractions (PVCs) in SCN10A−/−/CaMKIIδc+/T (p = 0.08, Unpaired two-tailed Student’s t-test), CaMKIIδc+/T (four mice); SCN10A−/−/CaMKIIδc+/T (three mice), four individual recordings each. Data were presented as mean values ± SEM. d Reduction of ventricular tachycardia (VT) incidence in SCN10A−/−/CaMKIIδc+/T (p < 0.05, Unpaired two-tailed Student’s t-test), CaMKIIδc+/T (four mice); SCN10A−/−/CaMKIIδc+/T (three mice), four individual recordings each. Data were presented as mean values ± SEM.

Similar articles

Cited by

References

    1. Despa S, Islam MA, Weber CR, Pogwizd SM, Bers DM. Intracellular Na(+) concentration is elevated in heart failure but Na/K pump function is unchanged. Circulation. 2002;105:2543–2548. - PubMed
    1. Maltsev VA, et al. Novel, ultraslow inactivating sodium current in human ventricular cardiomyocytes. Circulation. 1998;98:2545–2552. - PubMed
    1. Maltsev VA, Silverman N, Sabbah HN, Undrovinas AI. Chronic heart failure slows late sodium current in human and canine ventricular myocytes: implications for repolarization variability. Eur. J. Heart Fail. 2007;9:219–227. - PMC - PubMed
    1. Song Y, Shryock JC, Belardinelli L. An increase of late sodium current induces delayed afterdepolarizations and sustained triggered activity in atrial myocytes. AJP Hear. Circ. Physiol. 2008;294:H2031–H2039. - PubMed
    1. Valdivia CR, et al. Increased late sodium current in myocytes from a canine heart failure model and from failing human heart. J. Mol. Cell. Cardiol. 2005;38:475–483. - PubMed

Publication types

Substances